A recent study showed that TIPE2 can suppress the growth and aggressiveness of hepatocellular carcinoma cells through downregulation of the phosphoinositide 3-kinase/AKT signaling pathway [39]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.